Sanbo Brain Hospital, a Chinese privately-owned neurology specialist, has raised over 800 million yuan ($113 million) in a Series B round of equity financing led by China’s Taikang Asset Management.
A unit of Chinese investment bank CEC Capital, healthcare fund Park Road Medical Investment, Beijing-based equity investment firm Broadhi Capital, and Beijing Puhong Investment Fund Management participated in the financing.
